We found that similarly to bladder cancer (BC), KMT2C is downregulated in comparison with normal tissue in colorectal adenocarcinoma (COAD), non‐small‐cell lung cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC; Fig 1D). This evidence concerns the gene KMT2C and urinary bladder cancer.